8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS )

Metabolically activatable form of the PKA inhibitor Rp-8-Br-cAMPS
Cat. No.: B 010   CAS No.: [788807-32-9]   
Product Image



C14H16BrN5O6PS•Na; MW 516.2; λmax 264 nm; ε 17000; sodium salt; purity > 97% HPLC. For other salt forms please inquire. Lipophilic precursor of the protein kinase A inhibitor Rp-8-Br-cAMPS (Cat. No. B 001). During metabolic activation by esterases the inhibitor and butyrate are released. Caution: Butyrate was shown to have distinct biological effects! Significantly more lipophilic and membrane-permeant compared to Rp-8-Br-cAMPS. Detailed technical information and updated reference list available for Rp-8-Br-cAMPS on request. Reference: Ruiz-Velasco et al., Circ. Res., 82, 557 - 565 (1998).

Protected under patent DE 3802865.4 exclusively licensed to BIOLOG LSI

 



Forgot your password?
Register
Username:
Password:
What is new!

June 07, 2010

New NAD and cADPR analogues !

Latest additions to our expanding product line of NAD+ and cADPR analogues are:

8-Br-7-CH-cADP... [more...]

May 21, 2010

New Epac references !

Two new collaborative papers describing the use of the membrane-permeant Epac activator... [more...]